Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus.
about
Insulin analogues in type 1 diabetes mellitus: getting better all the time.Introduction of biosimilar insulins in Europe.LY2963016 Insulin Glargine and Insulin Glargine (Lantus) Produce Comparable Pharmacokinetics and Pharmacodynamics at Two Dose Levels.Efficacy and safety of biosimilar insulins compared to their reference products: A systematic review.A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus.
P2860
Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Duration of action of two insu ...... with type 1 diabetes mellitus.
@en
Duration of action of two insu ...... with type 1 diabetes mellitus.
@nl
type
label
Duration of action of two insu ...... with type 1 diabetes mellitus.
@en
Duration of action of two insu ...... with type 1 diabetes mellitus.
@nl
prefLabel
Duration of action of two insu ...... with type 1 diabetes mellitus.
@en
Duration of action of two insu ...... with type 1 diabetes mellitus.
@nl
P2093
P2860
P356
P1476
Duration of action of two insu ...... with type 1 diabetes mellitus.
@en
P2093
Christoph Kapitza
David Coutant
Eric Chen Quin Lam
Helle Linnebjerg
Laiyi Chua
Mary E Seger
P2860
P356
10.1111/DOM.12759
P577
2016-08-03T00:00:00Z